Manufacturer
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Contents
Montelukast Na
Indication
Prophylaxis of exercise-induced asthma, Chronic asthma, Allergic rhinitis.
Instruction
6-14 years as chewable tab: 5 mg; ≥15 years Same as adult dose. Doses to be taken 2 hours prior to exercise; no additional doses to be taken within 24 hours. Evaluate patient after 2-4 weeks of treatment.
Drug interaction
Decrease plasma concentration with CYP450 inducers (e.g. phenytoin, phenobarbital, rifampicin). Gemfibrozil may increase montelukast serum concentration.
Malaysia
